English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Open

Background  The aim of this study was to establish a minimally invasive defibrillation testing (DT) protocol for patients with implantable cardioverter defibrillators (ICDs).    Methods  Two different energy DTs were performed, immediately after (15 J‐DT) and 7 days after (≤10 J‐DT) device implantation, in 20 consecutive ICD implantation patients. Cardiac‐troponin T (c‐TNT) and heart‐type fatty acid binding protein (H‐FABP) levels were measured before implantation, 2 h after implantation, and 1 day after each DT. For an additional 122 patients with ICD, we retrospectively analyzed 203 DTs immediately and 7 days after device implantation.    Results  Serum c‐TNT levels were significantly elevated 2 h after 15 J‐DT [0.008 (0.004–0.019) vs. 0.053 (0.037–0.068) ng/mL,  p <0.001], but not ≤10 J‐DT [0.007 (0.004–0.018) ng/mL]. Similarly, serum H‐FABP levels were significantly elevated 2 h after 15 J‐DT (2.9±1.5 vs. 6.4±3.4 ng/mL,  p <0.001), but not ≤10 J‐DT (2.7±1.5 ng/mL). The changes in c‐TNT and H‐FABP levels between baseline and 2 h after DT were significantly greater for 15 J‐DT compared with ≤10 J‐DT [c‐TnT: 0.039 (0.029–0.060) vs. 0 (0–0.003) ng/mL,  p <0.001; H‐FABP: 3.6±2.8 vs. −0.16±1.1 ng/mL,  p <0.001]. The success rates of the initial shocks delivered for ventricular fibrillation were no different between ≤10 J‐DT (85% [78/92]) and ≥15 J‐DT (92% [103/111]).    Conclusions  Elevated levels of myocardial damage markers such as c‐TNT and H‐FABP were not found after ≤10 J‐DT. In addition, an acceptable success rate was confirmed in ≤10 J‐DT.

The association between defibrillation shock energy and acute cardiac damage in patients with implantable cardioverter defibrillators